Havrix

Hepatitis is a serious disease caused by a virus. The virus (strain HM175) is propagated in MRC-human diploid cells. Recommended Dose and Schedule.

HAVRIX should be administered by intramuscular injection only. Tell the person who is giving you the vaccine: If you have any severe, life-threatening allergies.

Preparation for Administration Shake well before use. Do not administer if it appears otherwise. Federal government websites often end in. Suspension for injection. A vaccine, inactivated.

Active immunizing agent. Risks of a vaccine reaction. With any medicine, including vaccines, there is a chance.

These are usually mild and go away on their own, but serious reactions are also possible. How many doses for Havrix? Who should not get vaccinated? What was the first vaccine?

Does Hep B have a vaccine? Our vaccines business develops, produces and distributes over 1. You can find an A-Z list of our vaccines available in the US below. HAVRIX prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects. Havrix Monodose Vaccine may contain traces of neomycin B sulfate, which is used during the manufacturing process (see section ). For the full list of excipients, see section 6. Find patient medical information for Havrix Intramuscular on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

See full prescribing information for HAVRIX. L dose administered intramuscularly and a 0. As part of our commitment to transparency, we are reporting the of all our research, where the outcomes are perceived to be positive or negative. QUALITATIVE AND QUANTITATIVE COMPOSITION.

Havrix is approved for people who are months and older. Both Havrix and Vaqta are available in pediatric and adult formulations. This website is funded and developed by GSK.

This site is intended for US healthcare professionals only. Trademarks are owned by or licensed to the GSK group of companies. Our open innovation strategy is designed to promote change beyond GSK by sharing expertise, resources intellectual property and know-how with external researchers and the scientific community in Australia and across the globe.

HAVRIX is approved for use in persons months of age and older.